A Phase 2/3 randomized, open label study of toca 511, a retroviral replicating vector, combined with Toca FC versus standard of care in subjects undergoing planned resection for recurrent glioblastoma or anaplastic astrocytoma

UCI-15-35
NCT02414165
Cancer - Brain and Nervous System
Daniela Bota
Open
Treatment
II/III
Adult
Local

For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.